J M Reich

Summary

Affiliation: Southern Iron Disorders Center
Country: USA

Publications

  1. ncbi Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy
    Jerome M Reich
    Center for Health Research, Kaiser Permanente, Northwest Region, Portland, OR, USA
    Chest 121:32-9. 2002
  2. ncbi Lung cancer growth dynamics
    Jerome M Reich
    Thoracic Oncology Program, Earle A Chiles Research Center, Department of Mathematics and Statistics, Portland State University, Portland, OR 97225 7007, United States
    Eur J Radiol 80:e458-61. 2011
  3. ncbi A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening
    J M Reich
    Thoracic Oncology Program, Earl A Chiles Research Institute, Portland Providence Medical Center, 7400 SW Barnes Rd, A622, Portland, OR 97225, USA
    Thorax 63:377-83. 2008
  4. ncbi Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy
    Jerome M Reich
    Earl A Chiles Research Institute, Portland Providence Medical Center, Att Claudia Haywood, Bldg A, 4805 NE Glisan St Portland, OR 97213, United States
    Lung Cancer 52:265-71. 2006
  5. ncbi Adverse long-term effect of corticosteroid therapy in recent-onset sarcoidosis
    Jerome M Reich
    Sarcoidosis Vasc Diffuse Lung Dis 20:227-34. 2003
  6. ncbi What is sarcoidosis?
    Jerome M Reich
    Chest 124:367-71. 2003
  7. ncbi Improved survival and higher mortality: the conundrum of lung cancer screening
    Jerome M Reich
    Chest 122:329-37. 2002
  8. ncbi Lung-cancer screening
    Jerome M Reich
    N Engl J Med 353:2194-5; author reply 2194-5. 2005
  9. ncbi Lung cancer screening: contumacy vs mendacity
    Jerome M Reich
    Chest 123:963-4. 2003
  10. ncbi A requirement for histologic confirmation of stage I sarcoidosis is far more likely to prove harmful than helpful
    Jerome M Reich
    Sarcoidosis Vasc Diffuse Lung Dis 24:77. 2007

Detail Information

Publications12

  1. ncbi Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy
    Jerome M Reich
    Center for Health Research, Kaiser Permanente, Northwest Region, Portland, OR, USA
    Chest 121:32-9. 2002
    ..To compare the sarcoidosis mortality in referral settings (RS) and population-based settings (PS), and to identify the contribution of stage, ethnicity, and corticosteroid therapy (CST) to their disparate outcomes...
  2. ncbi Lung cancer growth dynamics
    Jerome M Reich
    Thoracic Oncology Program, Earle A Chiles Research Center, Department of Mathematics and Statistics, Portland State University, Portland, OR 97225 7007, United States
    Eur J Radiol 80:e458-61. 2011
    ..For example, in the Mayo Clinic computerized tomography trial, stage IA tumor volume doubling time was 230 days...
  3. ncbi A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening
    J M Reich
    Thoracic Oncology Program, Earl A Chiles Research Institute, Portland Providence Medical Center, 7400 SW Barnes Rd, A622, Portland, OR 97225, USA
    Thorax 63:377-83. 2008
    ....
  4. ncbi Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy
    Jerome M Reich
    Earl A Chiles Research Institute, Portland Providence Medical Center, Att Claudia Haywood, Bldg A, 4805 NE Glisan St Portland, OR 97213, United States
    Lung Cancer 52:265-71. 2006
    ..Preliminary evidence from CT screening trials fails to support the premise that it diminishes the absolute number of advanced lung cancers...
  5. ncbi Adverse long-term effect of corticosteroid therapy in recent-onset sarcoidosis
    Jerome M Reich
    Sarcoidosis Vasc Diffuse Lung Dis 20:227-34. 2003
    ....
  6. ncbi What is sarcoidosis?
    Jerome M Reich
    Chest 124:367-71. 2003
  7. ncbi Improved survival and higher mortality: the conundrum of lung cancer screening
    Jerome M Reich
    Chest 122:329-37. 2002
  8. ncbi Lung-cancer screening
    Jerome M Reich
    N Engl J Med 353:2194-5; author reply 2194-5. 2005
  9. ncbi Lung cancer screening: contumacy vs mendacity
    Jerome M Reich
    Chest 123:963-4. 2003
  10. ncbi A requirement for histologic confirmation of stage I sarcoidosis is far more likely to prove harmful than helpful
    Jerome M Reich
    Sarcoidosis Vasc Diffuse Lung Dis 24:77. 2007
  11. ncbi Tissue verification of stage I sarcoidosis: the question is if, not how
    Jerome M Reich
    Chest 133:1529; author reply 1529-30. 2008
  12. ncbi Assessing the efficacy of lung cancer screening
    Jerome M Reich
    Radiology 238:398-401. 2006